TREOSULFAN- VERSUS BUSULFAN-BASED CONDITIONING IN ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANTATION FOR MYELODYSPLASTIC SYNDROME: A SINGLE-CENTRE RETROSPECTIVE PROPENSITY SCORE-MATCHED COHORT STUDY

被引:0
|
作者
Moya, Tommy Alfaro [1 ,2 ]
Remberger, Mats [3 ]
Chen, Carol [1 ]
Gerbitz, Armin [1 ,2 ]
Kim, Dennis Dong Hwan [1 ,2 ]
Kumar, Rajat [1 ,2 ]
Lam, Wilson [1 ,2 ]
Law, Arjun Datt [1 ,2 ]
Lipton, Jeffrey H. [1 ,2 ]
Michelis, Fotios V. [1 ,2 ]
Basso, Igor Novitzky [1 ,2 ]
Viswabandya, Auro [1 ,2 ]
Mattsson, Jonas [1 ,2 ]
Pasic, Ivan [1 ,2 ]
机构
[1] Princess Margaret Canc Ctr, Toronto, ON, Canada
[2] Univ Toronto, Toronto, ON, Canada
[3] Univ Uppsala Hosp, Uppsala, Sweden
关键词
D O I
暂无
中图分类号
Q6 [生物物理学];
学科分类号
071011 ;
摘要
O060
引用
收藏
页码:60 / 61
页数:2
相关论文
共 50 条
  • [21] Treosulfan and Fludarabine based Conditioning regimen in Pediatric Patients undergoing Allogeneic Hematopoietic Stem Cell Transplantation: A single centre experience
    Foell, J.
    Buerle, K.
    Dannenmaier, A-K.
    Jakob, M.
    Rebe, K.
    Corbacioglu, S.
    BONE MARROW TRANSPLANTATION, 2015, 50 : 5591 - 5591
  • [22] Conditioning with Busulfan plus Melphalan Versus Single-Agent Melphalan for Patients with Multiple Myeloma Receiving Autologous Stem Cell Transplantation: A Propensity Score-Matched Analysis
    Patel, Romil
    Milton, Denai R.
    Tanner, Mark R.
    Bashir, Qaiser
    Srour, Samer A.
    Saini, Neeraj Y.
    Lin, Paul
    Ramdial, Jeremy
    Nieto, Yago
    Lee, Hans C.
    Patel, Krina K.
    Gaballa, Mahmoud R.
    Tang, Guilin
    Aljawai, Yosra M.
    Kebriaei, Partow
    Thomas, Sheeba K.
    Orlowski, Robert Z.
    Champlin, Richard E.
    Shpall, Elizabeth J.
    Qazilbash, Muzaffar H.
    Pasvolsky, Oren
    BLOOD, 2024, 144 : 7019 - 7020
  • [23] Second Allogeneic Hematopoietic Stem-Cell Transplantation Using Fludarabine Treosulfan Conditioning Regimen in Patients Previously Treated with Busulfan-Based Regimens; Myeloablation with Acceptable Toxicity
    Shimoni, Avichai
    Rand, Avital
    Shem-Tov, Noga
    Hardan, Izhar
    Volchek, Yulia
    Maayaan, Hannah
    Yerushalmi, Ronit
    Nagler, Arnon
    BLOOD, 2009, 114 (22) : 888 - 889
  • [24] Final Evaluation of a Clinical Phase III Trial Comparing Treosulfan to Busulfan-Based Conditioning Therapy Prior to Allogeneic Hematopoietic Stem Cell Transplantation of Adult Acute Myeloid Leukemia and Myelodysplastic Syndrome Patients Ineligible to Standard Myeloablative Regimens
    Beelen, Dietrich
    Markiewicz, Miroslaw
    Stelljes, Matthias
    Remenyi, Peter
    Wagner-Drouet, Eva-Maria, III
    Dreger, Peter
    Bethge, Wolfgang
    Ciceri, Fabio
    Stoelzel, Friedrich
    Junghanss, Christian
    Michallet, Mauricette
    Schaefer-Eckart, Kerstin
    Grigoleit, Goetz
    Scheid, Christof
    Patriarca, Francesca
    Mico, Maria Caterina
    Niederwieser, Dietger
    Hilgendorf, Inken
    Russo, Domenico
    Socie, Gerard
    Holler, Ernst
    Glass, Bertram
    Wulf, Gerald
    Basara, Nadezda
    Hellmann, Andrzej
    Stuhler, Gernot
    Verbeek, Mareike
    Iori, Anna Paola
    Finke, Juergen
    Benedetti, Fabio
    Casper, Jochen
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2019, 25 (03)
  • [25] Allogeneic stem cell transplantation after a fludarabine/busulfan-based reduced-intensity conditioning in patients with myelodysplastic syndrome or secondary acute myeloid leukemia
    Kröger, N
    Bornhäuser, M
    Ehninger, G
    Schwerdtfeger, R
    Biersack, H
    Sayer, HG
    Wandt, H
    Schäfer-Eckardt, K
    Beyer, J
    Kiehl, M
    Zander, AR
    ANNALS OF HEMATOLOGY, 2003, 82 (06) : 336 - 342
  • [26] Outcomes of Pharmacokinetically Targeted Busulfan-Based Conditioning Regimen for Patients with Myelodysplastic Syndrome and Acute Myelogenous Leukemia Undergoing CD34 Selected Allogeneic Hematopoietic Stem Cell Transplantation
    Beyer, Kristen
    Proli, Anthony
    Zheng, Junting
    Devlin, Sean
    Bhatt, Valkal
    Lin, Andrew
    Papadopoulos, Esperanza B.
    Jakubowski, Ann A.
    Perales, Miguel
    Giralt, Sergio
    Castro-Malaspina, Hugo
    Tamari, Roni
    BLOOD, 2016, 128 (22)
  • [27] Outcomes of Pharmacokinetically Targeted Busulfan-Based Conditioning Regimen for Patients with Myelodysplastic Syndrome and Acute Myelogenous Leukemia Undergoing CD34 Selected Allogeneic Hematopoietic Stem Cell Transplantation
    Beyer, Kristen
    Proli, Anthony J.
    Zheng, Junting
    Bhatt, Valkal
    Lin, Andrew
    Papadopoulos, Esperanza B.
    Jakubowski, Ann A.
    Perales, Miguel-Angel
    Castro-Malaspina, Hugo
    Giralt, Sergio A.
    Tamari, Roni
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2017, 23 (03) : S263 - S263
  • [28] REDUCED TOXICITY TREOSULFAN-BASED VS. REDUCED INTENSITY BUSULFAN-BASED CONDITIONING REGIMEN IN AML/MDS PATIENTS UNDERGOING ALLOGENEIC HAEMATOPOIETIC CELL TRANSPLANTATION: PRELIMINARY RESULTS OF A SINGLE CENTRE EXPERIENCE
    Sakellari, I.
    Mallouri, D.
    Batsis, I.
    Charalampidou, S.
    Kaliou, M.
    Afisidis, A.
    Gavriilaki, E.
    Constantinou, V.
    Yannaki, E.
    Kaloyannidis, P.
    Apostolou, C.
    Sotiropoulos, D.
    Papalexandri, A.
    Vadikoliou, C.
    Smias, C.
    Anagnostopoulos, A.
    LEUKEMIA RESEARCH, 2015, 39 : S66 - S67
  • [29] Allogeneic stem cell transplantation after a fludarabine/busulfan-based reduced-intensity conditioning in patients with myelodysplastic syndrome or secondary acute myeloid leukemia
    N. Kröger
    M. Bornhäuser
    G. Ehninger
    R. Schwerdtfeger
    H. Biersack
    H. G. Sayer
    H. Wandt
    K. Schäfer-Eckardt
    J. Beyer
    M. Kiehl
    A. R. Zander
    Annals of Hematology, 2003, 82 : 336 - 342
  • [30] Allogeneic hematopoietic stem cell transplantation versus hypomethylating agents in patients with myelodysplastic syndrome: A retrospective casecontrol study
    Jabbour, Elias
    Mathisen, Michael S.
    Garcia-Manero, Guillermo
    Champlin, Richard
    Popat, Uday
    Khouri, Issa
    Giralt, Sergio
    Kadia, Tapan
    Chen, Julianne
    Pierce, Sherry
    Koca, Ebru
    Daver, Naval
    Tanaka, Maria
    Rondon, Gabriela
    Oran, Betul
    Parmar, Simrit
    Kantarjian, Hagop
    de Lima, Marcos
    AMERICAN JOURNAL OF HEMATOLOGY, 2013, 88 (03) : 198 - 200